Novigenix Announces First Closing of its $20M Series B
16 Nov 2022 //
ACCESSWIRE
Novigenix Announces Discovery of Liquid Biopsy Immunotherapy Response Biomarkers
08 Sep 2022 //
ACCESSWIRE
Novigenix and Philips Sign Technology License Agreement
09 Mar 2022 //
ACCESSWIRE
Novigenix-Led Consortium Secures Eurostars Funding
21 Jan 2020 //
BUSINESS WIRE
Novigenix and RadioMedix to Develop Neuroendocrine Cancer
15 Oct 2019 //
BIOSPACE

Market Place
Sourcing Support